Brief: Grifols Launches Fibrinogen Concentrate For Acute Bleeding Episodes In The U.S.
15/06/2026 13:05
BRIEF-Grifols Launches Fibrinogen Concentrate For Acute Bleeding Episodes In The U.S. June 15 (Reuters) - Grifols SA GRLS.MC:
LAUNCHES NEW FIBRINOGEN CONCENTRATE FESILTY (FIBRINOGEN, HUMAN-CHMT) IN THE U.S.
FESILTY TO BE USED FOR ACUTE BLEEDING EPISODES IN PEDIATRIC AND ADULT PATIENTS WITH CONGENITAL FIBRINOGEN DEFICIENCY
Further company coverage: GRLS.MC
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 567 69 66 00;))
Recent news on Grifols
See all newsSpanish stocks - Factors to watch on Nov 3
Brief: Grifols Approves Interim Dividend Of €0.15/Shr Payable On Dec 4
Brief: Grifols Q3 Group Profit €162 Mln
Refile: Grifols says Canada plasma license suspension has no impact on ongoing operations
Brief: Health Canada Suspends Licence Of Grifols Site In Winnipeg - Globe And Mail